-
Something wrong with this record ?
Cholinergic Anti-inflammatory Pathway and Stroke
K. Duris, J. Lipkova, M. Jurajda,
Language English Country United Arab Emirates
Document type Journal Article, Review
- MeSH
- alpha7 Nicotinic Acetylcholine Receptor physiology MeSH
- Central Nervous System physiology MeSH
- Stroke immunology physiopathology MeSH
- Humans MeSH
- Vagus Nerve physiology MeSH
- Spleen physiology MeSH
- Inflammation physiopathology MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
BACKGROUND: Stroke is devastating cerebrovascular event which is responsible for 6.7 million deaths each year worldwide. Inflammation plays an important role in the pathophysiology of stroke. Targeting inflammation after stroke is highly actual topic for both experimental and clinical research. METHODS: Research articles related to cholinergic anti-inflammatory pathway (CHAIP) and stroke were reviewed. The first part of review describes the basic characteristics of inflammatory response after stroke, main components and function of CHAIP. The second part reviews studies focused on CHAIP as a therapeutic target for ischemic and hemorrhagic stroke. Both pharmacological stimulation of α7 nAChR and vagus nerve stimulation after stroke are reviewed. RESULTS: Cholinergic anti-inflammatory pathway (CHAIP) is a physiological mechanism by which central nervous system regulates immune response and controls inflammation. Vagus nerve, spleen and α7 nicotinic acetylcholine receptor (α7 nAChR) are the main components of CHAIP. CONCLUSION: Targeting cholinergic anti-inflammatory pathway is a promising way of immunomodulation which attenuates inflammation in a complex manner without causing immunosuppression.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18025173
- 003
- CZ-PrNML
- 005
- 20180712093651.0
- 007
- ta
- 008
- 180709s2017 ts f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.2174/1567201814666170201150015 $2 doi
- 035 __
- $a (PubMed)28155595
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ts
- 100 1_
- $a Duris, Kamil $u Department of Pathological Physiology, Faculty of Medicine, Masaryk University Brno, Brno, Czech Republic.
- 245 10
- $a Cholinergic Anti-inflammatory Pathway and Stroke / $c K. Duris, J. Lipkova, M. Jurajda,
- 520 9_
- $a BACKGROUND: Stroke is devastating cerebrovascular event which is responsible for 6.7 million deaths each year worldwide. Inflammation plays an important role in the pathophysiology of stroke. Targeting inflammation after stroke is highly actual topic for both experimental and clinical research. METHODS: Research articles related to cholinergic anti-inflammatory pathway (CHAIP) and stroke were reviewed. The first part of review describes the basic characteristics of inflammatory response after stroke, main components and function of CHAIP. The second part reviews studies focused on CHAIP as a therapeutic target for ischemic and hemorrhagic stroke. Both pharmacological stimulation of α7 nAChR and vagus nerve stimulation after stroke are reviewed. RESULTS: Cholinergic anti-inflammatory pathway (CHAIP) is a physiological mechanism by which central nervous system regulates immune response and controls inflammation. Vagus nerve, spleen and α7 nicotinic acetylcholine receptor (α7 nAChR) are the main components of CHAIP. CONCLUSION: Targeting cholinergic anti-inflammatory pathway is a promising way of immunomodulation which attenuates inflammation in a complex manner without causing immunosuppression.
- 650 _2
- $a centrální nervový systém $x fyziologie $7 D002490
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a zánět $x patofyziologie $7 D007249
- 650 _2
- $a slezina $x fyziologie $7 D013154
- 650 _2
- $a cévní mozková příhoda $x imunologie $x patofyziologie $7 D020521
- 650 _2
- $a nervus vagus $x fyziologie $7 D014630
- 650 _2
- $a alfa7 nikotinové acetylcholinové receptory $x fyziologie $7 D064569
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Lipkova, Jolana $u Department of Pathological Physiology, Faculty of Medicine, Masaryk University Brno, Brno, Czech Republic.
- 700 1_
- $a Jurajda, Michal $u Institute of Pathological Physiology, Faculty of Medicine, Masaryk University Brno, Kamenice 5, 625 00 Brno, Czech Republic.
- 773 0_
- $w MED00008817 $t Current drug delivery $x 1875-5704 $g Roč. 14, č. 4 (2017), s. 449-457
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28155595 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180709 $b ABA008
- 991 __
- $a 20180712093944 $b ABA008
- 999 __
- $a ok $b bmc $g 1317304 $s 1022094
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 14 $c 4 $d 449-457 $i 1875-5704 $m Current drug delivery $n Curr Drug Deliv $x MED00008817
- LZP __
- $a Pubmed-20180709
